TITLE

pneumoventricle

PUB. DATE
January 2005
SOURCE
Taber's Cyclopedic Medical Dictionary;2005, p1700
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of the term "pneumoventricle" is presented. It refers to the air accumulation in the cerebral ventricles.
ACCESSION #
21241369

 

Related Articles

  • blood-brain barrier:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p40 

    A definition of the term "blood-brain barrier" is presented.

  • Blood-brain Barrier.  // Encyclopedic Reference of Molecular Pharmacology;2004, p184 

    A definition of the term "blood-brain barrier" is presented. It refers to a condition which arises because capillaries are permeable to water, glucose, sodium chloride and non-ionised lipid-soluble molecules. It is because to the presence of tight junctions between endothelial cells as well as...

  • Sanctuary Site.  // Encyclopedic Reference of Cancer;2001, p807 

    A definition of the term "sanctuary site" is presented. It refers to any location in the body that is poorly penetrated by drugs. The brain is said to be protected from antileukemic drugs by the blood-brain barrier.

  • Corrigendum to “Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood-Brain Barrier (BBB)”.  // Molecular Therapy;May2010, Vol. 18 Issue 5, p1054 

    A correction to the article "Directed Evolution of a Novel Adeno-Associated Virus (AAV) Vector That Crosses the Seizure-Compromised Blood-Brain Barrier (BBB)" that was published in the May 1, 2010 issue is presented.

  • Clinical aspects of the blood-brain barrier.  // British Medical Journal;7/17/1976, Vol. 2 Issue 6028, p133 

    Examines the clinical aspects of blood-brain barrier. Effect of differences in drug penetration; Role of endothelial cells in restricting the passage of molecules into the brain tissue; Physiochemical properties of drugs.

  • Effect of Diabetes on The Blood Brain Barrier. Horani, Mohamad H.; Mooradian, Arshag D. // Current Pharmaceutical Design;Apr2003, Vol. 9 Issue 10, p833 

    Diabetes mellitus is a metabolic disorder associated with structural and functional alteration of various organ systems including the central nervous system. The overall evidence suggests that the effect of Diabetes mellitus on the brain, although more subtle than some other chronic diabetic...

  • Interactions of Cytokines with the Blood-Brain Barrier: Implications for Feeding. Weihong Pan, Arshag D.; Kastin, Abba J. // Current Pharmaceutical Design;Apr2003, Vol. 9 Issue 10, p827 

    The blood-brain barrier (BBB) mediates interactions between the brain and the cytokines produced in the periphery. Some of these cytokines play significant roles in feeding behavior. This review will summarize various ways by which cytokines cross the BBB and discuss the implications of their...

  • Is Obesity a Disease of the Blood-Brain Barrier? Physiological, Pathological, and Evolutionary Considerations. Banks, William A. // Current Pharmaceutical Design;Apr2003, Vol. 9 Issue 10, p801 

    Leptin has emerged as a major regulator of body adiposity. The majority of humans with obesity have a resistance to leptin. Human and rodent studies indicate that the major cause of this resistance arises from an impaired ability of leptin to cross the blood-brain barrier, with lesser roles...

  • Insulin and the Blood-Brain Barrier. Woods, Stephen C.; Seeley, Randy J.; Baskin, Denis G.; Schwartz, Michael W. // Current Pharmaceutical Design;Apr2003, Vol. 9 Issue 10, p795 

    Although several possible mechanisms exist by which the pancreatic hormone, insulin, could enter the brain from the blood, most evidence suggests that the majority of it enters primarily by a receptor-mediated transport process. Many factors influence the rate of entry, including fasting and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics